BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 25124112)

  • 21. A unique and rapid approach toward the efficient development of novel protein tyrosine phosphatase (PTP) inhibitors based on 'clicked' pseudo-glycopeptides.
    Yang JW; He XP; Li C; Gao LX; Sheng L; Xie J; Shi XX; Tang Y; Li J; Chen GR
    Bioorg Med Chem Lett; 2011 Feb; 21(4):1092-6. PubMed ID: 21251827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological evaluation of newly synthesized quinoline-5,8-quinones as Cdc25B inhibitors.
    Cossy J; Belotti D; Brisson M; Skoko JJ; Wipf P; Lazo JS
    Bioorg Med Chem; 2006 Sep; 14(18):6283-7. PubMed ID: 16782352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, biological evaluation and 3D-QSAR studies of imidazolidine-2,4-dione derivatives as novel protein tyrosine phosphatase 1B inhibitors.
    Wang MY; Jin YY; Wei HY; Zhang LS; Sun SX; Chen XB; Dong WL; Xu WR; Cheng XC; Wang RL
    Eur J Med Chem; 2015 Oct; 103():91-104. PubMed ID: 26342135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and insulin-sensitising effects of novel PTP1B inhibitors.
    Tang YB; Lu D; Chen Z; Hu C; Yang Y; Tian JY; Ye F; Wu L; Zhang ZY; Xiao Z
    Bioorg Med Chem Lett; 2013 Apr; 23(8):2313-8. PubMed ID: 23499238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and biological evaluation of 2-substituted ethenesulfonic acid ester derivatives as selective PTP1B inhibitors.
    Liu J; Deng X; Jin Y; Xu B; Liu W; Jiang F; Fu L
    Pharmazie; 2015 Jul; 70(7):446-51. PubMed ID: 26373204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Aryl-furan derivatives bearing a phenylalanine- or isoleucine-derived rhodanine moiety as potential PTP1B inhibitors.
    Niu T; Wang P; Li C; Dou T; Piao H; Li J; Sun L
    Bioorg Chem; 2021 Jan; 106():104483. PubMed ID: 33268007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of potent and selective inhibitors targeting protein tyrosine phosphatase 1B (PTP1B).
    Jin J; Ye X; Boateng D; Dai K; Ye F; Du P; Yu H
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2358-2363. PubMed ID: 31221555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of 1,3,4-Thiadiazolyl-Containing Thiazolidine-2,4-dione Derivatives as Novel PTP1B Inhibitors with Antidiabetic Activity.
    Li M; Li H; Min X; Sun J; Liang B; Xu L; Li J; Wang SH; Xu X
    J Med Chem; 2024 May; 67(10):8406-8419. PubMed ID: 38723203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of 2,4,6-trihydroxychalcone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
    Sun LP; Gao LX; Ma WP; Nan FJ; Li J; Piao HR
    Chem Biol Drug Des; 2012 Oct; 80(4):584-90. PubMed ID: 22805439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular docking studies and biological evaluation of 1,3,4-thiadiazole derivatives bearing Schiff base moieties as tyrosinase inhibitors.
    Tang J; Liu J; Wu F
    Bioorg Chem; 2016 Dec; 69():29-36. PubMed ID: 27669118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Docking Assisted Prediction and Biological Evaluation of Sideritis L. Components with PTP1b Inhibitory Action and Probable Anti-Diabetic Properties.
    Eleftheriou P; Therianou E; Lazari D; Dirnali S; Micha A
    Curr Top Med Chem; 2019; 19(5):383-392. PubMed ID: 30806317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of heterocyclic ring-substituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.
    Qiu WW; Shen Q; Yang F; Wang B; Zou H; Li JY; Li J; Tang J
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6618-22. PubMed ID: 19846303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, kinetic, molecular dynamics, and hypoglycemic effect characterization of new and potential selective benzimidazole derivatives as Protein Tyrosine Phosphatase 1B inhibitors.
    Campos-Almazán MI; Flores-Ramos M; Hernández-Campos A; Castillo R; Sierra-Campos E; Torgeson K; Peti W; Valdez-Solana M; Oria-Hernández J; Méndez ST; Castillo-Villanueva A; Jiménez-de Jesús H; Avitia-Domínguez C; Téllez-Valencia A
    Bioorg Med Chem; 2021 Oct; 48():116418. PubMed ID: 34563877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of novel high potent and cellular active ADC type PTP1B inhibitors with selectivity over TC-PTP via modification interacting with C site.
    Du Y; Zhang Y; Ling H; Li Q; Shen J
    Eur J Med Chem; 2018 Jan; 144():692-700. PubMed ID: 29289892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity.
    Liu P; Du Y; Song L; Shen J; Li Q
    Eur J Med Chem; 2016 Aug; 118():27-33. PubMed ID: 27123900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of 4,4-dimethyl lithocholic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.
    He HB; Gao LX; Deng QF; Ma WP; Tang CL; Qiu WW; Tang J; Li JY; Li J; Yang F
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7237-42. PubMed ID: 23067554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EK-6136 (3-methyl-4-(O-methyl-oximino)-1-phenylpyrazolin-5-one): a novel Cdc25B inhibitor with antiproliferative activity.
    Kim KR; Kwon JL; Kim JS; No Z; Kim HR; Cheon HG
    Eur J Pharmacol; 2005 Dec; 528(1-3):37-42. PubMed ID: 16324698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro effects of cinnamic acid derivatives on protein tyrosine phosphatase 1B.
    Adisakwattana S; Pongsuwan J; Wungcharoen C; Yibchok-anun S
    J Enzyme Inhib Med Chem; 2013 Oct; 28(5):1067-72. PubMed ID: 22957721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of heterocyclic bis-aryl amides as novel Src homology 2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors.
    Satheeshkumar R; Zhu R; Feng B; Huang C; Gao Y; Gao LX; Shen C; Hou TJ; Xu L; Li J; Zhu YL; Zhou YB; Wang WL
    Bioorg Med Chem Lett; 2020 Jun; 30(11):127170. PubMed ID: 32273218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of novel bromophenol 3,4-dibromo-5-(2-bromo-3,4-dihydroxy-6-(isobutoxymethyl)benzyl)benzene-1,2-diol as protein tyrosine phosphatase 1B inhibitor and its anti-diabetic properties in C57BL/KsJ-db/db mice.
    Jiang B; Guo S; Shi D; Guo C; Wang T
    Eur J Med Chem; 2013 Jun; 64():129-36. PubMed ID: 23644196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.